Overview

A Double-Blind Study of E5555 in Japanese Patients With Acute Coronary Syndrome

Status:
Completed
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
The purpose of this study is to assess the safety and tolerability of E5555 in Japanese patients with acute coronary syndrome.
Phase:
Phase 2
Details
Lead Sponsor:
Eisai Co., Ltd.
Treatments:
Platelet Aggregation Inhibitors